Specifieke bijdrage van transgeen plasma en bloedplaatjes von Willebrand factor in hemostase en trombose: van functionele studies tot gentherapie.
Ontwikkeling van 'fiber optic surface plasmon resonance'- gebaseerde bepaling van von Willebrand factor hoeveelheid en activiteit
Studie van de dynamica van de von Willebrand factor en ADAMTS-13 met single molecule fluorescentiemicroscopie.
Doorgronden van von Willebrand factor en zijn protease ADAMTS13 aan de hand van single molecule fluorescentiemicroscopie.
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene: role of von Willebrand factor multimers and the von Wi
Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall
Factor VIII-von Willebrand Factor Binding Defects in Autosomal Recessive von Willebrand Disease Type Normandy and in Mild Hemophilia A New Insights into Factor VIII-von Willebrand Factor Interactions
Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease
Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.
Replication Data for: Peptidylarginine deiminase 4 and ADAMTS13 activity in Staphylococcus aureus bacteremia